Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Fulcrum Pharma

1999 FOUNDED
M&A STATUS
1-10 EMPLOYEES
Merger of Eq. LATEST DEAL TYPE
4 FINANCING ROUNDS
1 INVESTMENTS
Description

Provider of drug development support services intended to deliver products faster and more efficiently to the global pharmaceutical market. The company's drug development support services offers assistance to companies in various stages of drug development from research through approval and post-marketing, enabling pharmaceutical and biotechnology companies to achieve drug development and regulatory approval milestones.

Formerly Known As
Protodigm
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Consulting Services (B2B)
Other Industries
Drug Discovery
Acquirer
Former Stock Listing
FUL
Primary Office
  • Hemel One Boundary Way
  • Hemel Hempstead HP1 1JY
  • England, United Kingdom

Fulcrum Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Fulcrum Pharma‘s full profile, request access.

Request full access to PitchBook

Fulcrum Pharma Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 0000000000 19-Mar-2007 000000000000000000 00.000 Consulting Services (B2B) 000 00000
To view this company’s complete investment and acquisition history, request access »

Fulcrum Pharma Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Fulcrum Pharma‘s full profile, request access.

Request full access to PitchBook

Fulcrum Pharma Executive Team (2)

Name Title Board
Seat
Contact
Info
Jon Court Chief Executive Officer

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »